Search
Selpercatinib
go.drugbank.com/drugs/DB15685ApprovedInvestigationalSelpercatinib is a kinase inhibitor with enhanced specificity for RET tyrosine kinase receptors (RTKs) over other RTK classes. … [A202055, A202052, L13604] Enhanced RET (Rearranged during transfection) oncogene expression is a hallmark of many cancers.
Categories: MATE 1 Inhibitors, P-glycoprotein inhibitorsSynonyms: 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrileCedazuridine
go.drugbank.com/drugs/DB15694ApprovedInvestigationalAstex Pharmaceuticals Inc under the name INQOVI®. … Myelodysplastic syndromes (MDS) are a group of hematopoietic neoplasms that give rise to variable cytopenias progressing to secondary acute myeloid leukemia (sAML), which is invariably fatal if untreated
Categories: Heterocyclic Compounds, 1-RingSynonyms: (4R)-2'-Deoxy-2',2'-difluoro-3,4,5,6-tetrahydrouridineAmfenac
go.drugbank.com/drugs/DB15911InvestigationalAmfenac is an arylacetic acid derivative and a non0steroidal anti-inflammatory agent.[A275203, A275208]
Synonyms: (2-Amino-3-benzoylphenyl)acetic acidDiquafosol
go.drugbank.com/drugs/DB15919InvestigationalCategories: Heterocyclic Compounds, 1-RingProducts: DIQUAS-S ophthalmic solution 3%, DIQUAS Ophthalmic Solution 3%Menadione bisulfite
go.drugbank.com/drugs/DB15944InvestigationalMixtures: HEMOSIN K, HEMOSIN-KCategories: Vitamin KStrychnine
go.drugbank.com/drugs/DB15954ExperimentalCategories: Heterocyclic Compounds, 2-Ring, Compounds used in a research, industrial, or household settingHomochlorcyclizine
go.drugbank.com/drugs/DB15979InvestigationalCategories: Cytochrome P-450 CYP2D6 Inhibitors, Heterocyclic Compounds, 1-RingGarlic oil
go.drugbank.com/drugs/DB15989InvestigationalMixtures: Hovid Omega-3 + GarlicCategories: Cytochrome P-450 CYP2C19 Inhibitors, Cytochrome P-450 CYP2C9 InhibitorsIndocyanine green
go.drugbank.com/drugs/DB16024ApprovedInvestigationalWithdrawnCategories: Heterocyclic Compounds, 2-Ring, Compounds used in a research, industrial, or household settingPlixorafenib
go.drugbank.com/drugs/DB16038InvestigationalPLX8394 is under investigation in clinical trial NCT02428712 (A Study of PLX8394 as a Single Agent in Patients With Advanced Unresectable Solid Tumors).